PREHEVBRIO Pregnancy Outcomes Registry
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-12-08
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06097312
- Locations
- 🇺🇸
ProPharma, Recruiting Nationwide, Overland Park, Kansas, United States
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901e With E6020 Adjuvant
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- VBI Vaccines Inc.
- Registration Number
- NCT05614245
- Locations
- 🇨🇦
Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada
🇨🇦Red Maple Trials, Ottawa, Ontario, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a
- Conditions
- Interventions
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 103
- Registration Number
- NCT05548439
- Locations
- 🇨🇦
CHU de Québec Université Laval, Quebec, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada
Safety, Tolerability, and Immunogenicity of the COVID-19 Vaccine Candidates VBI-2902a and VBI-2905a
- Conditions
- Interventions
- First Posted Date
- 2021-02-26
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 114
- Registration Number
- NCT04773665
- Locations
- 🇨🇦
Manna Toronto, Toronto, Ontario, Canada
🇨🇦Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦LMC Manna - Bayview CPU, Toronto, Ontario, Canada
A Bridging Study: Comparing Two Lots of Sci-B-Vacâ„¢ and Engerix-B in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2020-08-28
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 402
- Registration Number
- NCT04531098
- Locations
- 🇻🇳
National Institute of Hygiene and Epidemiology (NIHE), Hanoi, Vietnam
Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
- First Posted Date
- 2019-12-24
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT04209400
- Locations
- 🇷🇺
Saint Petersburg State Budgetary Healthcare Institution, Saint Petersburg, Mirgorodskaya, Russian Federation
A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vacâ„¢
- First Posted Date
- 2019-11-27
- Last Posted Date
- 2022-06-24
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT04179786
Lot-to-lot Consistency of Sci-B-Vacâ„¢ in Adults
- First Posted Date
- 2018-01-24
- Last Posted Date
- 2021-03-25
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 2838
- Registration Number
- NCT03408730
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium
🇬🇧Oxford University, Oxford, Oxfordshire, United Kingdom
🇫🇮University of Tampere, Tampere, Finland
Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2020-07-17
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 1607
- Registration Number
- NCT03393754
- Locations
- 🇨🇦
BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada
🇺🇸Rapid Medical Research, Cleveland, Ohio, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- Conditions
- Interventions
- First Posted Date
- 2017-12-26
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- VBI Vaccines Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT03382977
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸The Valley Hospital - Neurosurgeons of New Jersey, Ridgewood, New Jersey, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States